Keymed Biosciences Inc.

HKEX:2162.HK

31.3 (HKD) • At close December 24, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 27.34127.34113.48613.486163.562163.5620.0320.032505055.13555.135000000
Kosten van de omzet 1.8681.86810.93110.9317.5097.5090.0240.0241.2691.2698.68.6000000
Brutowinst 25.47325.4732.5552.555156.054156.0540.0080.00848.73248.73246.53546.535000000
Brutowinstmarge 0.9320.9320.1890.1890.9540.9540.2380.2380.9750.9750.8440.844000000
Onderzoek- en ontwikkelingskosten 165.513165.513173.263173.263124.879124.879171.683171.68382.00482.00483.54883.54895.53195.53143.73243.73219.96919.969
Algemene en administratieve kosten 44.97444.97447.31747.31741.18641.18641.43241.43225.52425.52432.80932.80913.41813.4186.9896.9893.7863.786
Verkoop- en marketingkosten 11.62411.6240021.658027.7360000000-0.054-0.0540.0540.054
Verkoop-, algemene en administratieve kosten 56.59856.59847.31747.31741.18641.18641.43241.43225.52425.52432.80932.80913.41813.4186.9356.9353.843.84
Overige kosten 000000000000000000
Bedrijfskosten 222.111222.111220.58223.892148.354148.354168.06168.0655.43755.437177.662177.6621,813.1291,813.129387.428387.42817.58317.583
Bedrijfsresultaat -196.638-196.638-218.025-218.514-10.202-10.202-213.449-213.449-58.797-58.797-71.112-71.112-109.138-109.138-50.682-50.682-23.808-23.808
Bedrijfsresultaat ratio -7.192-7.192-16.167-16.204-0.062-0.062-6,776.159-6,776.159-1.176-1.176-1.29-1.29000000
Totaal overige inkomsten en kosten netto 31.37631.37615.85816.34734.08434.08460.38960.38960.05960.059-59.989-59.989-1,706.078-1,706.078-341.015-341.0156.0656.065
Inkomen voor belasting -165.262-165.262-202.167-202.16724.07324.073-153.061-153.0611.2621.262-131.101-131.101-1,815.216-1,815.216-391.681-391.681-17.743-17.743
Inkomen voor belasting ratio -6.044-6.044-14.991-14.9910.1470.147-4,859.063-4,859.0630.0250.025-2.378-2.378000000
Belastingkosten 3.043.040.7990.7993.7040.5899.3673.724-1.465-1.465-1.696-1.696-0.966-0.966-0.133-0.13300
Nettowinst -168.373-168.373-203.162-203.16223.48423.484-156.785-156.7852.7272.727-129.405-129.405-1,814.25-1,814.25-391.549-391.549-17.743-17.743
Nettowinstmarge -6.158-6.158-15.065-15.0650.1440.144-4,977.286-4,977.2860.0550.055-2.347-2.347000000
WPA (Winst Per Aandeel) -0.64-0.64-0.78-0.780.090.09-0.6-0.60.010.01-0.51-0.51-27.04-27.04-5.84-5.84-0.26-0.26
Verwaterde WPA -0.64-0.64-0.78-0.780.0880.088-0.6-0.60.010.01-0.51-0.51-27.04-27.04-5.84-5.84-0.26-0.26
EBITDA -177.899-177.899-201.948-201.948-0.953-0.953-206.678-206.678-54.431-54.431-68.392-68.392-105.457-105.457-46.7-46.7-20.843-20.843
EBITDA ratio -6.507-6.507-14.975-14.975-0.006-0.006-6,561.19-6,561.19-1.089-1.089-1.24-1.24000000